Skip to main content
SpringerLink
Log in

Setting New Standards for Nasal Vestibule Malignancies

  • Chapter
  • First Online:
Malignancies of the Nasal Vestibule

  • 107 Accesses

Abstract

In this concluding chapter, we outline three fundamental paradigm shifts in the oncology of the nasal vestibule.

First, the classification needs to be changed, by defining the nasal vestibule as a subsite of the nose and paranasal sinuses and separating it from the “nasal cavity proper and ethmoid.” The anatomic boundaries should therefore be changed and made reliable and easy to identify, also radiologically. A specific topographic code should be assigned, with specific T-classification criteria derived from specific characteristics of cancers arising in this site. This will improve both prognostic stratification and treatment selection and also provide a better estimation of the real prevalence, which is underestimated due to the absence of a specific topographic code in cancer registries, but also because of frequent misdiagnosis with skin cancers, due to the early straightforward invasion of the skin by these primaries. For this reason, we recommend every lesion of the nasal and perinasal skin to be routinely evaluated by an otolaryngologist, to exclude a nasal vestibule primary.

Secondly, there is increasing evidence demonstrating that Interventional Radiotherapy (IRT, Brachytherapy, BT), is at least equivalent to surgery and superior to EBRT for the treatment of early-stage (T1 and T2 according to Wang) primary lesions in terms of oncological outcomes. Moreover, IRT appears superior to both aforementioned modalities in terms of cosmetic and functional results. Considering these findings, we recommend HDR (High Dose Rate) IRT as the new standard for the treatment of the primary lesion in nasal vestibule carcinoma.

As for neck treatment in N+ disease, a neck dissection remains the treatment of choice, as it is a safe and effective modality with both a staging and a curative role. Furthermore, it meshes well with IRT for the primary tumor and leaves room for further radical treatment by external beam radiation (see Chap. 14). Elective neck treatment in cN0 disease remains a topic of ongoing discussion, but is not recommended as of today. We believe that ultrasound investigation associated when deemed useful to USguided fine needle aspiration biopsy in a Lump Clinic can be extremely useful for the assessment of the real neck status and the proper definition of cN0 necks. The role of sentinel node biopsy in high-risk node negative nasal vestibule carcinoma is currently being evaluated.

Thirdly, to optimize the advantages of IRT as the primary therapeutic modality, we propose an evolved approach to the implantation phase of IRT, for which the main criterion becomes anatomy, that is an exploitation of the anatomic planes of esthetic and functional nose surgery to avoid previously described septal and alar perforation (anatomic implantation). The potential of intensity-modulated and image-guided IRT (IM-IRT and IG-IRT) will be in turn exploited to compensate for dose inhomogeneities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Jeannon JP, Riddle PJ, Irish J, O’sullivan B, Brown DH, Gullane P. Prognostic indicators in carcinoma of the nasal vestibule. Clin Otolaryngol. 2007;32(1):19–23.

    Article  PubMed  Google Scholar 

  2. Vital D, Morand G, Huber GF, Studer G, Holzmann D. Outcome in squamous cell carcinoma of the nasal vestibule: a single center experience. Head Neck. 2015;37(1):46–51.

    Article  PubMed  Google Scholar 

  3. Agger A, von Buchwald C, Madsen AR, et al. Squamous cell carcinoma of the nasal vestibule 1993-2002: a nationwide retrospective study from DAHANCA. Head Neck. 2009;31(12):1593–9.

    Article  PubMed  Google Scholar 

  4. Amin MB. AJCC: Cancer staging manual. 8th ed. New York, NY: Springer; 2017.

    Book  Google Scholar 

  5. Bussu F, Tagliaferri L, Mattiucci G, et al. Comparison of interstitial brachytherapy and surgery as primary treatments for nasal vestibule carcinomas. Laryngoscope. 2016;126(2):367–71.

    Article  PubMed  Google Scholar 

  6. Tagliaferri L, Fionda B, Bussu F, et al. Interventional radiotherapy (brachytherapy) for squamous cell carcinoma of the nasal vestibule: a multidisciplinary systematic review. Eur J Dermatol. 2019;29(4):417–21.

    Article  CAS  PubMed  Google Scholar 

  7. Bussu F, Tagliaferri L, Mattiucci G, et al. HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies. Head Neck. 2019;41:1667.

    Article  PubMed  Google Scholar 

  8. Wang CC. Treatment of carcinoma of the nasal vestibule by irradiation. Cancer. 1976;38(1):100–6.

    Article  CAS  PubMed  Google Scholar 

  9. Levendag PC, Nijdam WM, van Moolenburgh SE, et al. Interstitial radiation therapy for early-stage nasal vestibule cancer: a continuing quest for optimal tumor control and cosmesis. Int J Radiat Oncol Biol Phys. 2006;66(1):160–9.

    Article  PubMed  Google Scholar 

  10. Bussu F, Tagliaferri L, Piras A, Rizzo D, Tsatsaris N, De Corso E, Parrilla C, Paludetti G. Multidisciplinary approach to nose vestibule malignancies: setting new standards. Approccio multidisciplinare ai tumori maligni del vestibolo del naso: verso la definizione di nuovi standard. Acta Otorhinolaryngologica Italica. 2021;41(Suppl. 1):S158–S165. https://doi.org/10.14639/0392-100X-suppl.1-41-2021-16.

  11. Bussu F, et al. New standards for the management of nose vestibule malignancies. Acta Oto-Laryngologica. 2023;143(3):215–22. https://doi.org/10.1080/00016489.2023.2179662.

  12. Evaluation of Staging Systems for Cancer of the Nasal Vestibule Cancers. 2023;15(11):3028. https://doi.org/10.3390/cancers15113028.

  13. Petrone G, Rossi ED, Gallus R, Petrelli L, Marrone S, Rizzo D, Piras A, Garofalo G, Rindi G, Galli J, et al. Utility of ultrasound-guided fine needle aspiration cytology in assessing malignancy in head and neck pathology. Cytopathology. 2021;32:407–15. https://doi.org/10.1111/cyt.12955.

    Article  PubMed  Google Scholar 

  14. Czerwinski MD, Jansen PP, Zwijnenburg EM, Al-Mamgani A, Vergeer MR, Langendijk JA, Wesseling FWR, Kaanders JHAM, Verhoef CG. Radiotherapy as nasal preservation treatment strategy for cancer of the nasal vestibule: the Dutch experience. Radiother Oncol. 2021;164:20–6. https://doi.org/10.1016/j.radonc.2021.08.018. Epub 2021 Sep 4. PMID: 34487765.

    Article  PubMed  Google Scholar 

  15. Horsmans JD, Godballe C, Jorgensen KE, Bastholt L, Lontoft E. Squamous cell carcinoma of the nasal vestibule. Rhinology. 1999;37(3):117–21.

    CAS  PubMed  Google Scholar 

  16. Guinot JL, Rembielak A, Perez-Calatayud J, et al. GEC-ESTRO ACROP recommendations in skin brachytherapy. Radiother Oncol. 2018;126(3):377–85.

    Article  PubMed  Google Scholar 

  17. Goepfert H. The vex and fuss about nasal vestibule cancer. Head Neck. 1999;21(5):383–4.

    Article  CAS  PubMed  Google Scholar 

  18. Lipman D, Verhoef LC, Takes RP, Kaanders JH, Janssens GO. Outcome and toxicity profile after brachytherapy for squamous cell carcinoma of the nasal vestibule. Head Neck. 2015;37(9):1297–303.

    Article  PubMed  Google Scholar 

  19. Koopmann M, Weiss D, Savvas E, Rudack C, Stenner M. Clinicopathological and immunohistochemical characteristics of surgically treated primary carcinoma of the nasal vestibule- an evaluation of 30 cases. Clin Otolaryngol. 2014;40:240.

    Article  Google Scholar 

  20. Preoperative Diagnosis of Warthin Tumors Combining Cytological Clinical and Ultrasonographic Information within a Multidisciplinary Approach in a Lump Clinic Journal of Personalized Medicine. 2023;13(7):1075. https://doi.org/10.3390/jpm13071075.

  21. Bussu F, Tagliaferri L, De Corso E, et al. Functional results of exclusive interventional radiotherapy (brachytherapy) in the treatment of nasal vestibule carcinomas. Brachytherapy. 2020;20:178.

    Article  PubMed  Google Scholar 

  22. Czerwinski MD, van Leeuwen RGH, Kaanders J, et al. Image guided brachytherapy for cancer of the nasal vestibule: local control and cosmesis. Int J Radiat Oncol Biol Phys. 2019;103(4):913–21.

    Article  PubMed  Google Scholar 

  23. Lancellotta V, Kovacs G, Tagliaferri L, et al. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer. J Geriatr Oncol. 2019;10(3):514–7.

    Article  PubMed  Google Scholar 

  24. Langendijk JA, Poorter R, Leemans CR, de Bree R, Doornaert P, Slotman BJ. Radiotherapy of squamous cell carcinoma of the nasal vestibule. Int J Radiat Oncol Biol Phys. 2004;59(5):1319–25.

    Article  PubMed  Google Scholar 

  25. Wagenblast J, Baghi M, Helbig M, et al. Craniofacial reconstructions with bone-anchored epithesis in head and neck cancer patients--a valid way back to self-perception and social reintegration. Anticancer Res. 2008;28(4C):2349–52.

    PubMed  Google Scholar 

  26. Mendenhall WM, Stringer SP, Cassisi NJ, Mendenhall NP. Squamous cell carcinoma of the nasal vestibule. Head Neck. 1999;21(5):385–93.

    Article  CAS  PubMed  Google Scholar 

  27. Mirza N, Lanza DC. The nasal airway and obstructed breathing during sleep. Otolaryngol Clin N Am. 1999;32(2):243–62.

    Article  CAS  Google Scholar 

  28. Nonaka S, Unno T, Ohta Y, Mori S. Sneeze-evoking region within the brainstem. Brain Res. 1990;511(2):265–70.

    Article  CAS  PubMed  Google Scholar 

  29. Kilic C, Tuncel U, Comert E, Kaya BV. The effect of radiotherapy on mucociliary clearance in patients with laryngeal and nasopharyngeal cancer. Eur Arch Otorhinolaryngol. 2015;272(6):1517–20.

    Article  PubMed  Google Scholar 

  30. Alvarez-Camacho M, Gonella S, Campbell S, Scrimger RA, Wismer WV. A systematic review of smell alterations after radiotherapy for head and neck cancer. Cancer Treat Rev. 2017;54:110–21.

    Article  CAS  PubMed  Google Scholar 

  31. Kamel R, Al-Badawy S, Khairy A, Kandil T, Sabry A. Nasal and paranasal sinus changes after radiotherapy for nasopharyngeal carcinoma. Acta Otolaryngol. 2004;124(4):532–5.

    Article  PubMed  Google Scholar 

  32. Surico G, Muggeo P, Mappa L, et al. Impairment of nasal mucociliary clearance after radiotherapy for childhood head cancer. Head Neck. 2001;23(6):461–6.

    Article  CAS  PubMed  Google Scholar 

  33. Holscher T, Seibt A, Appold S, et al. Effects of radiotherapy on olfactory function. Radiother Oncol. 2005;77(2):157–63.

    Article  PubMed  Google Scholar 

  34. Stringer SP, Stiles W, Slattery WH III, et al. Nasal mucociliary clearance after radiation therapy. Laryngoscope. 1995;105(4 Pt 1):380–2.

    Article  CAS  PubMed  Google Scholar 

  35. Riva G, Boita M, Ravera M, et al. Nasal cytological changes as late effects of radiotherapy for nasopharyngeal cancer. Am J Rhinol Allergy. 2015;29(2):e41–5.

    Article  PubMed  Google Scholar 

  36. Tagliaferri L, Bussu F, Rigante M, et al. Endoscopy-guided brachytherapy for sinonasal and nasopharyngeal recurrences. Brachytherapy. 2015;14(3):419–25.

    Article  PubMed  Google Scholar 

  37. Tagliaferri L, Bussu F, Fionda B, et al. Perioperative HDR brachytherapy for reirradiation in head and neck recurrences: single-institution experience and systematic review. Tumori. 2017;103(6):516–24.

    Article  PubMed  Google Scholar 

  38. Mor N, Blitzer A. Functional anatomy and oncologic barriers of the larynx. Otolaryngol Clin N Am. 2015;48(4):533–45.

    Article  Google Scholar 

  39. Sandell LJ. Novel functions for type II procollagen. Connect Tissue Res. 2014;55(1):20–5.

    Article  CAS  PubMed  Google Scholar 

  40. Caccialanza M, Piccinno R, Percivalle S, Rozza M. Radiotherapy of carcinomas of the skin overlying the cartilage of the nasal: our experience in 671 lesions. J Eur Acad Dermatol Venereol. 2009;23(9):1044–9.

    Article  CAS  PubMed  Google Scholar 

  41. Caccialanza M, Piccinno R, Moretti D, Rozza M. Radiotherapy of carcinomas of the skin overlying the cartilage of the nasal: results in 405 lesions. Eur J Dermatol. 2003;13(5):462–5.

    PubMed  Google Scholar 

  42. Caccialanza M, Piccinno R, Gaiani F, Contini D. Relevance of dermatologic radiotherapy in the therapeutic strategy of skin epithelial neoplasms: excellent results in the treatment of lesions localized on eyelids and skin overlying the cartilage of the nasal. G Ital Dermatol Venereol. 2013;148(1):83–8.

    CAS  PubMed  Google Scholar 

  43. Caccialanza M, Bertani E, Piccinno R, Rozza M, Brambilla R, Percivalle S. Radiotherapy of T4 squamous cell carcinoma of the skin of nasal pyramid. J Eur Acad Dermatol Venereol. 2006;20(7):872–4.

    Article  CAS  PubMed  Google Scholar 

  44. Chargari C, Van Limbergen E, Mahantshetty U, Deutsch E, Haie-Meder C. Radiobiology of brachytherapy: the historical view based on linear quadratic model and perspectives for optimization. Cancer Radiother. 2018;22(4):312–8.

    Article  CAS  PubMed  Google Scholar 

  45. Tagliaferri L, Vavassori A, Lancellotta V, De Sanctis V, Barbera F, Fusco V, Vidali C, Fionda B, Colloca G, Gambacorta MA, Aristei C, Corvò R, Magrini SM. Can brachytherapy be properly considered in the clinical practice? Trilogy project: the vision of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy study group. J Contemp Brachyther. 2020;12(1):84–9. Epub 2020 Feb 28. PMID: 32190074; PMCID: PMC7073336.

    Article  Google Scholar 

  46. Czerwinski MD, Verhoef CG, Kaanders JHAM Sentinel NOSE study: prospective registration study on the sentinel node procedure for bulky squamous cell carcinoma of the nasal vestibule. Identifier: NCT05637307. 2023. https://clinicaltrials.gov/ct2/show/NCT05637307?cond=sentinel+nose&draw=2&rank=1.

Download references

Author information

Authors and Affiliations

  1. Otolaryngology Division, Azienda Ospedaliera Universitaria di Sassari, Sassari, Italy

    Francesco Bussu

  2. Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy

    Francesco Bussu

  3. UOC Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy

    Luca Tagliaferri & Vincenzo Valentini

  4. Radiation Oncology, Radboud University Medical Centre, Nijmegen, Netherlands

    Michal Czerwinski & Lia Verhoef

  5. Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK

    Agata Rembielak

  6. Otolaryngology Division, Azienda Ospedaliera Universitaria, Sassari, Italy

    Claudia Crescio

  7. Gemelli-INTERACTS, Università Cattolica del Sacro Cuore, Rome, Italy

    Gyorgy Kovacs

  8. Unit of Otorhinolaryngology, “A. Gemelli” University Hospital Foundation, IRCCS, Rome, Italy

    Jacopo Galli

  9. Department of Head-Neck and Sensory Orngans, Università Cattolica del Sacro Cuore, Rome, Italy

    Jacopo Galli

Authors
  1. Francesco Bussu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Luca Tagliaferri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michal Czerwinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Agata Rembielak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claudia Crescio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lia Verhoef
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gyorgy Kovacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jacopo Galli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Vincenzo Valentini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudia Crescio .

Editor information

Editors and Affiliations

  1. Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy

    Francesco Bussu

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bussu, F. et al. (2023). Setting New Standards for Nasal Vestibule Malignancies. In: Bussu, F. (eds) Malignancies of the Nasal Vestibule. Springer, Cham. https://doi.org/10.1007/978-3-031-32850-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-32850-3_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-32849-7

  • Online ISBN: 978-3-031-32850-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation